MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine, Drug Discovery, Development & Delivery
2020: Most bankruptcies – Endpoints News
Melinta Therapeutics (MLNT-NASDAQ), formerly, RIB-X
Organization & Developments: Melinta
Parents
Melinta Therapeutics (MLNT-NASDAQ), formerly, RIB-X
Children
2019: Hedge Funds Are Dumping Melinta Therapeutics, Inc. (MLNT)
2019: In starved antibiotic field, Melinta soars as FDA grants speedy drug review – Endpoints News
2019: Melinta Therapeutics stock slides after company files for chapter 11 bankruptcy protection
2019: Melinta: Can This Antibiotic Innovator Overcome Industry Headwinds?_seekingalpha.com
Melinta Therapeutics is dedicated to the discovery, development and commercialization of groundbreaking antibiotics to overcome drug-resistant, life-threatening infections.
Rib-X Pharmaceuticals
Jumps
*Key People: Melinta
Finance & Acquisitions: Melinta